IRIS
FRANZESE, Ciro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.810
EU - Europa 1.066
AS - Asia 594
AF - Africa 156
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 9
Totale 6.654
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.776
SG - Singapore 298
FI - Finlandia 290
IE - Irlanda 231
CN - Cina 199
NG - Nigeria 153
DE - Germania 122
FR - Francia 92
IT - Italia 83
SE - Svezia 74
NL - Olanda 64
GB - Regno Unito 50
CA - Canada 32
IN - India 28
TR - Turchia 25
IL - Israele 23
BE - Belgio 16
HK - Hong Kong 12
AU - Australia 9
CZ - Repubblica Ceca 9
A2 - ???statistics.table.value.countryCode.A2??? 6
CL - Cile 6
RU - Federazione Russa 6
PL - Polonia 5
RO - Romania 5
ES - Italia 4
GR - Grecia 4
IR - Iran 4
NO - Norvegia 4
AT - Austria 3
BR - Brasile 3
EU - Europa 3
BD - Bangladesh 2
EG - Egitto 2
JP - Giappone 2
MX - Messico 2
UA - Ucraina 2
KE - Kenya 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 6.654
Salva come PNG Salva come JPEG
Città #
Wilmington 1.079
Chandler 761
San Mateo 411
Helsinki 290
Ann Arbor 287
Dublin 230
Singapore 208
Leawood 198
Boardman 195
Lawrence 186
Princeton 186
Shanghai 183
Benin City 153
Woodbridge 121
Fairfield 107
New York 97
Ashburn 91
Paris 91
Amsterdam 61
Milan 50
London 36
Norwalk 26
Kocaeli 25
Toronto 24
Seattle 18
Brussels 16
Monmouth Junction 16
San Diego 14
Los Angeles 13
Santa Clara 13
Phoenix 12
Des Moines 10
Milwaukee 10
Falkenstein 8
Pune 8
Redwood City 8
Brno 6
Genoa 5
Apo 4
Redmond 4
Buffalo 3
Central District 3
Clearwater 3
Cupertino 3
Durham 3
Hanover 3
Kemerovo 3
Munich 3
New Berlin 3
São Paulo 3
Vaddangi 3
Andover 2
Augusta 2
Berlin 2
Chennai 2
Collegeville 2
Council Bluffs 2
Eden Prairie 2
Farmington 2
Frankfurt am Main 2
Guangzhou 2
Houston 2
Jacksonville 2
Moscow 2
Niagara Falls 2
Olomouc 2
Poznan 2
Shimla 2
Sydney 2
Tilburg 2
Tokyo 2
Vienna 2
Warsaw 2
Ardabil 1
Athens 1
Belleville 1
Berbenno 1
Bracknell 1
Cairo 1
Cambridge 1
Cinisello Balsamo 1
Edinburgh 1
Edmonton 1
Elk Grove Village 1
Fagnano Olona 1
Fort Simpson 1
Fountain Valley 1
Garching 1
Gosford 1
Guangling 1
Guiyang 1
Gunzenhausen 1
Hamilton 1
Hangzhou 1
Hunedoara 1
Huntington Beach 1
Iasi 1
Imola 1
Kilcoy 1
Lissone 1
Totale 5.365
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 95
ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS): Single Center Experience 75
Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? Analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy 67
Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation. 60
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 60
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 60
Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation 58
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 58
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. 57
SBRT for unresectable locally advanced pancreatic cancer: clinical outcomes on 100 patients 56
Hypofractionated stereotactic radiation therapy in skull base meningiomas 55
Can HSRS on tumor bed replace WBRT in resected brain metastases? Results of a phase II study 55
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 55
A Radiomic Approach to Predict Nodal and Distant Relapse in Patients Treated with Stereotactic Body Radiation Therapy for Early Stage NSCLC 54
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 53
The use of radiation therapy for oligoprogressive/oligopersistent oncogene driven non small cell lung cancer: state of the art 53
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients. 52
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent. 51
Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation 50
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer 50
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 49
Accuracy of fine-needle aspiration cytology in detecting cervical node metastasis after radiotherapy: Systematic review and meta-analysis 49
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 48
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 48
Randomized phase II study of hypofractionated WBI versus APBI using VMAT: early toxicity results 47
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing 47
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. 46
Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation Therapy 46
Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience 45
Results of a feed-back learning process for RapidPlan knowledge based planning 45
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT) 45
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 45
RapidPlan knowledge based planning: iterative learning process and model ability to steer planning strategies 45
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 45
Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy 45
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 45
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 44
RE-IRRADIATION OF LOCALLY RECURRENT PROSTATE CANCER: RESULTS OF EFFICACY AND SAFETY 44
Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy 44
Critical Appraisal of the Treatment Planning Performance of Volumetric Modulated Arc Therapy by Means of a Dual Layer Stacked Multileaf Collimator for Head and Neck, Breast, and Prostate 44
Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity 44
Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy. 44
Surgery Followed by Hypofractionated Radiosurgery on the Tumor Bed in Oligometastatic Patients With Large Brain Metastases. Results of a Phase 2 Study 44
SBRT for oligometastatic gynecological cancer: a single institution experience 43
Adenoid cystic carcinoma of the breast The double face of an exocrine gland carcinoma 43
Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification? 43
RapidPlan head and neck model: the objectives and possible clinical benefit. 42
Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis. 42
Randomized Phase III Trial Comparing Gamma Knife and Linac Based (EDGE) Approaches for Brain Metastases Radiosurgery: Results from the Gadget Trial 42
Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer. 42
Stereotactic Body Radiation Therapy in Oligometastatic Ovarian Cancer A Promising Therapeutic Approach 42
STEREOTACTIC BODY RADIATION THERAPY AS LOCAL TREATMENT FOR OLIGOMETASTASES FROM PROSTATE CANCER: EFFICACY AND IMPACT ON SYSTEMIC TREATMENT 42
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery. 41
Role of preoperative radiotherapy in rare retroperitoneal sarcoma 41
Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome 41
SABR in inoperable liver oligometastatic patients and radioresistant primary tumors 41
Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases? 41
Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors 40
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. 40
The role of SBRT in oligometastatic patients with liver metastases from breast cancer 40
Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis 40
Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question 39
ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial (vol 13, 166, 2018) 39
Role of stereotactic body radiation therapy in the management of oligometastatic pancreatic cancer single institution experience 39
Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy. 39
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 39
HYPOFRACTIONATED RADIATION THERAPY (OVER 3 WEEKS) CAN REPLACE CONVENTIONAL RADIATION THERAPY SCHEDULE (OVER 6 WEEKS) IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS? THE TIMES ARE RIPE 39
Role of extra cranial stereotactic body radiation therapy in the management of Stage IV melanoma 38
Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy. 38
Role of Radiotherapy in the management of metastases from salivary gland carcinoma. 38
External Beam Re-Irradiation of Locally Recurrent Prostate Cancer with FFF-VMAT 38
Outcome Evaluation of Patients with Limited Brain Metastasis From Malignant Melanoma, Treated with Surgery, Radiation Therapy, and Targeted Therapy. 38
Role of SBRT in the treatment of liver metastases: clinical results and prognostic factors 38
Imaging biomarkers in primary brain tumours 38
The Potential Role of Intensity-modulated Proton Therapy in the Regional Nodal Irradiation of Breast Cancer: A Treatment Planning Study 38
Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy. 37
Moderate hypofractionation and SIB with volumetric modulated arc therapy (RapidArc) for anal cancer 37
Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution 37
Volumetric modulated arc therapy for thoracic node metastases: a safe and effective treatment for a neglected disease. 37
Discrepancies between UICC and AJCC TNM classifications for oral cavity tumors in the 8th editions and following versions 36
HYPOFRACTIONATED STEREOTACTIC RADIATION THERAPY (HSRT) IN SKULL BASE MENINGIOMAS 36
Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up 36
VMAT SBRT For Localized Prostate Cancer: 4-Year Follow-Up And Correlation With WHO2016 Grade Groups 36
Predictive factors for survival outcomes of oligometastatic prostate cancer patients treated with metastases-directed therapy: a recursive partitioning-based analysis 36
Impact of hypofractionated schemes in radiotherapy for locally advanced head and neck cancer patients. 36
Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series 36
Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma 35
RANDOMIZED PHASE III TRIAL COMPARING GAMMA KNIFE (GK) AND LINAC BASED (EDGE) RADIOSURGERY FOR BRAIN METASTASES FROM SOLID TUMORS: RESULTS FROM THE GADGET TRIAL 35
STEREOTACTIC BODY RADIATION THERAPY (SBRT) VS. MODERATE HYPOFRACTIONATED RADIOTHERAPY IN PROSTATE CANCER: PROPENSITY-SCORE BASED COMPARISON OF OUTCOME AND TOXICITY 35
ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial 34
Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma 34
On the ability of a knowledge based planning process to improve itself 34
Toxicity profile of locally advanced head and neck cancer patients treated in 30 or 33 fractions RT 34
Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature 34
Role of stereotactic body radiation therapy for lung metastases from radio-resistant primary tumours. 34
Hypofractionated stereotactic RS for patients with brain metastases. Outcome evaluation and toxicity 34
Outcome evaluation of patients with diagnosed WHO grade III glioma treated according to the molecular profile, the hystology, and the extent of resection (EOR) 34
Treatment: Outcome and Toxicity of Volumetric Modulated Arc Therapy in Oropharyngeal Carcinoma. 33
Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy. 33
SURGERY FOLLOWED BY FRACTIONATED RADIOSURGERY ON THE TUMOR BED IN PATIENTS WITH SINGLE LARGE BRAIN METASTASES FROM SOLID TUMOR: PRELIMINARY RESULTS OF A PHASE II STUDY 33
Totale 4.382
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202068 0 0 0 0 0 0 0 0 0 0 0 68
2020/20211.962 23 18 9 17 7 601 263 149 445 220 8 202
2021/2022983 62 7 8 217 6 4 42 150 88 89 278 32
2022/20232.300 401 84 230 242 192 163 1 173 405 229 162 18
2023/20241.463 72 167 327 80 45 145 58 70 70 32 152 245
2024/202539 39 0 0 0 0 0 0 0 0 0 0 0
Totale 6.815